Repligen | RGEN - Des Atouts

Prix De L'Action
116.35
Variation Quotidienne
2.47 2.17%
Mensuellement
-13.60%
Annuel
-19.84%
Q1 Prévisions
110.46




Des Atouts Changement Date
Agilent USD 12.81B 86M 2025-12
Align Technology USD 6.23B 141K 2025-12
Bio Techne USD 2.52B 3.45M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Bruker USD 6.24B 193.5M 2025-12
Charles River Laboratories USD 7.14B 378.39M 2025-12
Danaher USD 83.46B 3.57B 2025-12
Dentsply International USD 5.43B 224M 2025-12
Exact Sciences USD 5.86B 39.38M 2025-12
General Electric Aerospace USD 130.17B 1.93B 2025-12
Henry Schein USD 11.22B 118M 2025-12
Illumina USD 6.64B 467M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 706.6M 21.5M 2025-12
OraSure Technologies USD 403.17M 19.93M 2025-12
Pacific Biosciences Of California USD 784.08M 19.08M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Repligen USD 2.95B 25.99M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Standard Biotools USD 567.75M 28.12M 2025-12
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Waters USD 5.08B 221.41M 2025-12
West Pharmaceutical Services USD 4.27B 164.2M 2025-12